| |
Paul
Edelstein, M.D.
Dr. Edelstein is
the Director of the Clinical Microbiology Laboratory. His current areas
of interest include Legionnaires disease, molecular pathogenesis of
bacterial infections, pneumonia, and antimicrobial chemotherapy.
Selected publications:
Berjohn CM, Fishman NO, Joffe MM, Edelstein PH, Metlay JP. Treatment and outcomes for patients with bacteremic pneumococcal pneumonia. Medicine (Baltimore) 2008;87:160-166.
Miyazaki S, Ishikawa F, Shimizu K, Ubagai T, Edelstein PH, Yamaguchi K. Gr-1high polymorphonuclear leukocytes and NK cells act via IL-15 to clear intracellular Haemophilus influenzae in experimental murine peritonitis and pneumonia. J Immunol, 2007;179:5407-5414.
Connolly LE, Edelstein PH, Ramakrishnan L. Why is long-term therapy required to cure tuberculosis? PLOS Medicine 2007, Vol. 4, No. 3, e120 doi:10.1371/journal.pmed.0040120.
Edelstein PH, Hu B, Shinzato T, Edelstein MAC, Xu W, Bessman MJ. Legionella pneumophila NudA is a Nudix hydrolase and virulence factor. Infect Immun 2005;73:6567-6576.
Contact:
Paul H. Edelstein, M.D.
7 Founders
3400 Spruce Street
Philadelphia, PA 19104-4283
phe@mail.med.upenn.edu
(215) 662-6651
Education:
Medical School: UCLA Medical School
ID Training: Wadsworth VA Medical Center
Academic Rank: Professor of Pathology and Laboratory Medicine
|
